Retrospective analysis of local injection site adverse reactions associated with 230 allogenic administrations of bone marrow-derived mesenchymal stem cells in 164 horses.
T L UrsiniL L AmelseHoda ElkhenanyAgricola OdoiJ L Carter-ArnoldHenry S AdairMadhu S DharPublished in: Equine veterinary journal (2018)
Fully characterised allogenic BM-MSCs originating from a single donor horse can be administered to horses with soft tissue injuries with a low rate of adverse reaction. The Summary is available in Portuguese - see Supporting Information.